相似文献
1
Mixed micelles made of poly(ethylene glycol)-phosphatidylethanolamine conjugate and d-alpha-tocopheryl polyethylene glycol 1000 succinate as pharmaceutical nanocarriers for camptothecin.
Int J Pharm. 2005 Dec 8;306(1-2):142-9. doi: 10.1016/j.ijpharm.2005.08.026. Epub 2005 Oct 19.
2
Preparation and characterization of Pluronic/TPGS mixed micelles for solubilization of camptothecin.
Colloids Surf B Biointerfaces. 2008 Jul 15;64(2):194-9. doi: 10.1016/j.colsurfb.2008.01.021. Epub 2008 Feb 5.
3
Mixed PEG-PE/vitamin E tumor-targeted immunomicelles as carriers for poorly soluble anti-cancer drugs: improved drug solubilization and enhanced in vitro cytotoxicity.
Eur J Pharm Biopharm. 2008 Sep;70(1):51-7. doi: 10.1016/j.ejpb.2008.04.016. Epub 2008 Apr 29.
4
Development and evaluation of vitamin E d-α-tocopheryl polyethylene glycol 1000 succinate-mixed polymeric phospholipid micelles of berberine as an anticancer nanopharmaceutical.
Int J Nanomedicine. 2016 Apr 26;11:1687-700. doi: 10.2147/IJN.S103332. eCollection 2016.
5
Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG).
Int J Pharm. 2010 Jun 15;392(1-2):170-7. doi: 10.1016/j.ijpharm.2010.03.056. Epub 2010 Apr 2.
6
Preparation of camptothecin-loaded polymeric micelles and evaluation of their incorporation and circulation stability.
Int J Pharm. 2006 Feb 3;308(1-2):183-9. doi: 10.1016/j.ijpharm.2005.10.030.
7
Camptothecin in sterically stabilized phospholipid micelles: a novel nanomedicine.
Nanomedicine. 2005 Mar;1(1):77-84. doi: 10.1016/j.nano.2004.11.002.
8
Novel Soluplus(®)-TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines.
Colloids Surf B Biointerfaces. 2016 Apr 1;140:403-411. doi: 10.1016/j.colsurfb.2016.01.003. Epub 2016 Jan 7.
9
Preparation and properties of mixed micelles made of Pluronic polymer and PEG-PE.
J Colloid Interface Sci. 2008 Jan 1;317(1):326-31. doi: 10.1016/j.jcis.2007.09.053. Epub 2007 Sep 22.
10
Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance.
ACS Appl Mater Interfaces. 2015 Aug 19;7(32):18064-75. doi: 10.1021/acsami.5b04995. Epub 2015 Aug 5.
引用本文的文献
1
Cationic Vitamin E-TPGS Mixed Micelles of Berberine to Neutralize Doxorubicin-Induced Cardiotoxicity via Amelioration of Mitochondrial Dysfunction and Impeding Apoptosis.
Molecules. 2024 Mar 5;29(5):1155. doi: 10.3390/molecules29051155.
2
Preparation, Optimization and Characterization of Fluticasoneloaded Mixed Micelles Based on Stearic Acid-g-chitosan as a Pulmonary Delivery System.
Recent Adv Drug Deliv Formul. 2024;18(1):61-76. doi: 10.2174/0126673878262764240208054140.
3
Enhancing Ezetimibe Anticancer Activity Through Development of Drug Nano-Micelles Formulations: A Promising Strategy Supported by Molecular Docking.
Int J Nanomedicine. 2023 Nov 15;18:6689-6703. doi: 10.2147/IJN.S438704. eCollection 2023.
4
TPGS Decorated Liposomes as Multifunctional Nano-Delivery Systems.
Pharm Res. 2023 Jan;40(1):245-263. doi: 10.1007/s11095-022-03424-6. Epub 2022 Nov 14.
5
Design, Fabrication and Evaluation of Stabilized Polymeric mixed micelles for Effective Management in Cancer Therapy.
Pharm Res. 2022 Nov;39(11):2761-2780. doi: 10.1007/s11095-022-03395-8. Epub 2022 Sep 28.
6
One-Pot, One-Step Synthesis of Drug-Loaded Magnetic Multimicelle Aggregates.
Bioconjug Chem. 2022 May 18;33(5):969-981. doi: 10.1021/acs.bioconjchem.2c00167. Epub 2022 May 6.
7
Inulin and Its Application in Drug Delivery.
Pharmaceuticals (Basel). 2021 Aug 26;14(9):855. doi: 10.3390/ph14090855.
8
Drug-Loaded Lipid-Core Micelles in Mucoadhesive Films as a Novel Dosage Form for Buccal Administration of Poorly Water-Soluble and Biological Drugs.
Pharmaceutics. 2020 Nov 30;12(12):1168. doi: 10.3390/pharmaceutics12121168.
9
Functional nano-vector boost anti-atherosclerosis efficacy of berberine in mice.
Acta Pharm Sin B. 2020 Sep;10(9):1769-1783. doi: 10.1016/j.apsb.2020.03.005. Epub 2020 Apr 8.
10
A Novel pH-Tunable Secondary Conformation Containing Mixed Micellar System in Anticancer Treatment.
Cancers (Basel). 2020 Feb 21;12(2):503. doi: 10.3390/cancers12020503.
本文引用的文献
1
Block copolymer design for camptothecin incorporation into polymeric micelles for passive tumor targeting.
Pharm Res. 2004 Nov;21(11):2001-8. doi: 10.1023/b:pham.0000048190.53439.eb.
2
Solubilization and stabilization of camptothecin in micellar solutions of pluronic-g-poly(acrylic acid) copolymers.
J Control Release. 2004 Jul 7;97(3):537-49. doi: 10.1016/j.jconrel.2004.04.007.
3
Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles.
J Control Release. 2004 Jun 18;97(2):249-57. doi: 10.1016/j.jconrel.2004.03.013.
4
Micelles from lipid derivatives of water-soluble polymers as delivery systems for poorly soluble drugs.
Adv Drug Deliv Rev. 2004 May 7;56(9):1273-89. doi: 10.1016/j.addr.2003.12.004.
5
PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio.
Pharm Res. 2003 Nov;20(11):1864-72. doi: 10.1023/b:pham.0000003387.15428.42.
6
Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs.
Pharm Res. 2003 Feb;20(2):297-302. doi: 10.1023/a:1022243709003.
7
Polyethylene glycol-diacyllipid micelles demonstrate increased acculumation in subcutaneous tumors in mice.
Pharm Res. 2002 Oct;19(10):1424-9. doi: 10.1023/a:1020488012264.
8
Camptothecin delivery methods.
Pharm Res. 2002 Oct;19(10):1389-99. doi: 10.1023/a:1020427227285.
9
PEG-based micelles as carriers of contrast agents for different imaging modalities.
Adv Drug Deliv Rev. 2002 Feb 21;54(2):235-52. doi: 10.1016/s0169-409x(02)00019-4.
10
Current perspectives on the clinical experience, pharmacology, and continued development of the camptothecins.
Clin Cancer Res. 2002 Mar;8(3):641-61.
Zotero 插件